Masaharu Takahashi, Tsutomu Nishizawa, Akira Nishizono, Manri Kawakami, Yukihiro Sato, Kazunori Kawakami, Masahiko Irokawa, Tomoko Tamaru, Shinichi Miyazaki, Mizuho Shimada, et al. Recent decline in hepatitis E virus prevalence among wild boars in Japan: Probably due to countermeasures implemented in response to outbreaks of classical swine fever virus infection. Virus research. 2024. 348. 199438-199438
Shigeo Nagashima, Putu Prathiwi Primadharsini, Takashi Nishiyama, Masaharu Takahashi, Kazumoto Murata, Hiroaki Okamoto. Development of a HiBiT-tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform. JOURNAL OF VIROLOGY. 2023
Masaharu Takahashi, Satoshi Kunita, Tsutomu Nishizawa, Hiroshi Ohnishi, Putu Prathiwi Primadharsini, Shigeo Nagashima, Kazumoto Murata, Hiroaki Okamoto. Infection Dynamics and Genomic Mutations of Hepatitis E Virus in Naturally Infected Pigs on a Farrow-to-Finish Farm in Japan: A Survey from 2012 to 2021. VIRUSES-BASEL. 2023. 15. 7
Kazumoto Murata, Masashi Mizokami. Possible biological mechanisms of entecavir versus tenofovir disoproxil fumarate on reducing the risk of hepatocellular carcinoma. Journal of gastroenterology and hepatology. 2023. 38. 5. 683-691
Putu Prathiwi Primadharsini, Shigeo Nagashima, Toshinori Tanaka, Suljid Jirintai, Masaharu Takahashi, Kazumoto Murata, Hiroaki Okamoto. Development and Characterization of Efficient Cell Culture Systems for Genotype 1 Hepatitis E Virus and Its Infectious cDNA Clone. VIRUSES-BASEL. 2023. 15. 4
Nao Nishida, Masaya Sugiyama, Hiromi Sawai, Sohji Nishina, Aiko Sakai, Keisuke Kakisaka, Keisuke Hino, Ryo Sumazaki, Yasuhiro Takikawa, Kazumoto Murata, et al. HLA-DRB1-DQB1 haplotypes and BTNL2 gene associate with response to a hepatitis B vaccine. HEPATOLOGY. 2017. 66. 796A-797A
Naohiko Masaki, Masaaki Korenaga, Mikio Yanase, Yuichi Nozaki, Shintaro Mikami, Yoshihiko Aoki, Masatoshi Imamura, Kazumoto Murata, Tatsuya Kanto, Masashi Mizokami. Effects of interferon-free treatment on serum cholesterol levels are different between the two sofosbuvir-based regimens in chronic HCV-infected patients. HEPATOLOGY. 2016. 64. 981A-981A
Kazumoto Murata, Akihiro Matsumoto, Masaya Sugiyama, Eiji Tanaka, Taisuke Inoue, Minoru Sakamoto, Nobuyuki Enomoto, Masao Honda, Shuichi Kaneko, Hiroyuki Gatanaga, et al. Induction of IFN-lambda 3 as an Additional Effect of Nucleotide, Not Nucleoside, Analogs: A New Potential Target for Hepatitis B Virus Infection. HEPATOLOGY. 2016. 64. 306A-306A